Armistice Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $97.8M | Buy |
|
|||||
|
2025
Q2 | $85M | Sell |
|
|||||
|
2025
Q1 | $111M | Buy |
|
|||||
|
2024
Q4 | $122M | Buy |
|
|||||
|
2024
Q3 | $20.9M | Sell |
|
|||||
|
2024
Q2 | $135M | Sell |
|
|||||
|
2024
Q1 | $141M | Sell |
|
|||||
|
2023
Q4 | $138M | Sell |
|
|||||
|
2023
Q3 | $137M | Sell |
|
|||||
|
2023
Q2 | $156M | Buy |
|
|||||
|
2023
Q1 | $161M | Buy |
|
|||||
|
2022
Q4 | $107M | Sell |
|
|||||
|
2022
Q3 | $141M | Hold |
|
|||||
|
2022
Q2 | $129K | Buy |
|
|||||
|
2022
Q1 | $60.9M | Buy |
|